Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Holte

Showing results (11-20 of 97) with videos related to

Pageof 10
Sort By:
Journal of Hematotherapy|October 1, 1996
Immunomagnetic purging of lymphoma cells from autograftsG Kvalheim, H Holte, E Jakobsen, et al.
European Journal of Haematology|August 4, 2004
ICE (ifosfamide, carboplatin, etoposide) as second-line chemotherapy in relapsed or primary progressive aggressive lymphoma--the Nordic Lymphoma Group experienceM Jerkeman, S Leppä, S Kvaløy, et al.
Social Science & Medicine (1982)|May 11, 2012
The decision to vaccinate a child: an economic perspective from southern MalawiJon H Holte, Ottar Mæstad, Jagrati V Jani
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|April 17, 2013
Triage systems for pre-hospital emergency medical services - a systematic reviewIngeborg Beate Lidal, Hilde H Holte, Gunn Elisabeth Vist
British Journal of Cancer|July 17, 1998
Tumour cell proliferation, but not apoptosis, predicts survival in B-cell non-Hodgkin's lymphomasT Stokke, E B Smeland, S Kvaløy, et al.
European Journal of Cancer (Oxford, England : 1990)|September 7, 2000
Prognostic factors in 140 adult patients with non-Hodgkin's lymphoma with systemic central nervous system (CNS) involvement. A single centre analysisA Hollender, S Kvaloy, K Lote, et al.
Spine|October 3, 2000
Socioeconomic factors and disability retirement from back pain: a 1983-1993 population-based prospective study in NorwayK B Hagen, H H Holte, K Tambs, et al.
Leukemia & Lymphoma|August 1, 2002
M-FISH cytogenetic analysis of non-Hodgkin lymphomas with t(14;18)(q32;q21) and add(1)(p36) as a secondary abnormality shows that the extra material often comes from chromosome arm 17qH Aamot, F Micci, H Holte, et al.
British Journal of Cancer|April 5, 2007
Post-treatment parenthood in Hodgkin's lymphoma survivorsC E Kiserud, A Fosså, H Holte, et al.
Bone Marrow Transplantation|October 12, 1999
Do patients who are treated with stem cell transplantation have a health-related quality of life comparable to the general population after 1 year?M Hjermstad, H Holte, S Evensen, et al.
Pageof 10

Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
Journal of Hematotherapy|October 1, 1996
Immunomagnetic purging of lymphoma cells from autograftsG Kvalheim, H Holte, E Jakobsen, et al.
European Journal of Haematology|August 4, 2004
ICE (ifosfamide, carboplatin, etoposide) as second-line chemotherapy in relapsed or primary progressive aggressive lymphoma--the Nordic Lymphoma Group experienceM Jerkeman, S Leppä, S Kvaløy, et al.
Social Science & Medicine (1982)|May 11, 2012
The decision to vaccinate a child: an economic perspective from southern MalawiJon H Holte, Ottar Mæstad, Jagrati V Jani
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|April 17, 2013
Triage systems for pre-hospital emergency medical services - a systematic reviewIngeborg Beate Lidal, Hilde H Holte, Gunn Elisabeth Vist
British Journal of Cancer|July 17, 1998
Tumour cell proliferation, but not apoptosis, predicts survival in B-cell non-Hodgkin's lymphomasT Stokke, E B Smeland, S Kvaløy, et al.
European Journal of Cancer (Oxford, England : 1990)|September 7, 2000
Prognostic factors in 140 adult patients with non-Hodgkin's lymphoma with systemic central nervous system (CNS) involvement. A single centre analysisA Hollender, S Kvaloy, K Lote, et al.
Spine|October 3, 2000
Socioeconomic factors and disability retirement from back pain: a 1983-1993 population-based prospective study in NorwayK B Hagen, H H Holte, K Tambs, et al.
Leukemia & Lymphoma|August 1, 2002
M-FISH cytogenetic analysis of non-Hodgkin lymphomas with t(14;18)(q32;q21) and add(1)(p36) as a secondary abnormality shows that the extra material often comes from chromosome arm 17qH Aamot, F Micci, H Holte, et al.
British Journal of Cancer|April 5, 2007
Post-treatment parenthood in Hodgkin's lymphoma survivorsC E Kiserud, A Fosså, H Holte, et al.
Bone Marrow Transplantation|October 12, 1999
Do patients who are treated with stem cell transplantation have a health-related quality of life comparable to the general population after 1 year?M Hjermstad, H Holte, S Evensen, et al.
Pageof 10